LncRNA SBF2-AS1 Promotes Diffuse Large B-Cell Lymphoma Growth by Regulating FGFR2 via Sponging miR-494-3p

被引：13

作者：

Fu, Dong-Wei ^{[1
]}

Liu, Ai-Chun ^{[1
]}

机构：

[1] Harbin Med Univ, Dept Hematol, Canc Hosp, Harbin 150081, Heilongjiang, Peoples R China

来源：

CANCER MANAGEMENT AND RESEARCH | 2021年 / 13卷

关键词：

diffuse large B-cell lymphoma; SBF2-AS1; miR-494-3p; FGFR2; tumorigenesis; EXPRESSION; CANCER; BIOMARKER; RECEPTOR; DNA;

D O I：

10.2147/CMAR.S284258

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Purpose: Currently, there is no efficient and feasible method for diffuse large B-cell lymphoma (DLBCL) in clinical practice, and the main reason is the unclear pathogenesis of DLBCL, which leads to a high fatality rate of DLBCL. Methods: Therefore, it is meaningful to explore the molecular mechanism of DLBCL and find a targeted therapeutic approach from the molecular level. Results: Long non-coding RNA (lncRNA) SBF2-AS1 was highly expressed in DLBCL tissues and cell lines. Silencing of SBF2-AS1 inhibited the viability and growth of OCI-LY-3 cells. Furthermore, SBF2-AS1 acted as a sponge of miR-494-3p and inhibited its expression. And miR-494-3p directly targeted FGFR2. Functionally, forced expression of miR-494-3p or knockdown of FGFR2 removed the promoted effects of lncRNA SBF2-AS1 on DLBCL development. In vivo tumorigenesis experiments indicated SBF2-AS1 accelerated tumor growth via miR-494-3p/FGFR2 axis. Conclusion: Our study revealed that SBF2-AS1 promoted the growth of DLBCL, which were mediated by miR-494-3p/FGFR2 axis.

引用

页码：571 / 578

页数：8

共 26 条

[1] A Molecular Portrait of High-Grade Ductal Carcinoma In Situ [J].

Abba, Martin C. ;

Gong, Ting ;

Lu, Yue ;

Lee, Jaeho ;

Zhong, Yi ;

Lacunza, Ezequiel ;

Butti, Matias ;

Takata, Yoko ;

Gaddis, Sally ;

Shen, Jianjun ;

Estecio, Marcos R. ;

Sahin, Aysegul A. ;

Aldaz, C. Marcelo .

CANCER RESEARCH, 2015, 75 (18) :3980-3990

[2] Cell-free DNA as a biomarker in diffuse large B-cell lymphoma: A systematic review [J].

Arzuaga-Mendez, Javier ;

Prieto-Fernandeza, Endika ;

Lopez-Lopez, Elixabet ;

Martin-Guerrero, Idoia ;

Carlos Garcia-Ruiz, Juan ;

Garcia-Orad, Africa .

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2019, 139 :7-15

[3] Pretargeted delivery of PI3K/mTOR small-molecule inhibitor-loaded nanoparticles for treatment of non-Hodgkin's lymphoma [J].

Au, Kin Man ;

Wang, Andrew Z. ;

Park, Steven, I .

SCIENCE ADVANCES, 2020, 6 (14)

[4] Long noncoding RNAs in B-cell development and activation [J].

Brazao, Tiago F. ;

Johnson, Jethro S. ;

Muller, Jennifer ;

Heger, Andreas ;

Ponting, Chris P. ;

Tybulewicz, Victor L. J. .

BLOOD, 2016, 128 (07) :E10-E19

[5] Long noncoding RNAs in cancer: From discovery to therapeutic targets [J].

Choudhari, Ramesh ;

Sedano, Melina J. ;

Harrison, Alana L. ;

Subramani, Ramadevi ;

Lin, Ken Y. ;

Ramos, Enrique I. ;

Lakshmanaswamy, Rajkumar ;

Gadad, Shrikanth S. .

ADVANCES IN CLINICAL CHEMISTRY, VOL 95, 2020, 95 :105-147

[6] Aberrant NEAT1_1 expression may be a predictive marker of poor prognosis in diffuse large B cell lymphoma [J].

Deng, Lan ;

Jiang, Ling ;

Tseng, Kuo-Fu ;

Liu, Yuan ;

Zhang, Xing ;

Dong, Ruihong ;

Lu, Zhigang ;

Wang, Xiuju .

CANCER BIOMARKERS, 2018, 23 (02) :157-164

[7] A feed-forward regulatory loop between androgen receptor and PlncRNA-1 promotes prostate cancer progression [J].

Fang, Ziyu ;

Xu, Chen ;

Li, Yaoming ;

Cai, Xiaobing ;

Ren, Shancheng ;

Liu, Houqi ;

Wang, Yue ;

Wang, Fubo ;

Chen, Rui ;

Qu, Min ;

Wang, Yang ;

Zhu, Yasheng ;

Zhang, Wei ;

Shi, Xiaolei ;

Yao, Jingjing ;

Gao, Xu ;

Hou, Jianguo ;

Xu, Chuanliang ;

Sun, Yinghao .

CANCER LETTERS, 2016, 374 (01) :62-74

[8] Triple Angiokinase Inhibitor Nintedanib Directly Inhibits Tumor Cell Growth and Induces Tumor Shrinkage via Blocking Oncogenic Receptor Tyrosine Kinases [J].

Hilberg, Frank ;

Tontsch-Grunt, Ulrike ;

Baum, Anke ;

Le, Anh T. ;

Doebele, Robert C. ;

Lieb, Simone ;

Gianni, Davide ;

Voss, Tilman ;

Garin-Chesa, Pilar ;

Haslinger, Christian ;

Kraut, Norbert .

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2018, 364 (03) :494-503

[9] LncRNA-HGBC stabilized by HuR promotes gallbladder cancer progression by regulating miR-502-3p/SET/AKT axis [J].

Hu, Yun-ping ;

Jin, Yun-peng ;

Wu, Xiang-song ;

Yang, Yang ;

Li, Yong-sheng ;

Li, Huai-feng ;

Xiang, Shan-shan ;

Song, Xiao-ling ;

Jiang, Lin ;

Zhang, Yi-jian ;

Huang, Wen ;

Chen, Shi-li ;

Liu, Fa-tao ;

Chen, Chen ;

Zhu, Qin ;

Chen, Hong-zhuan ;

Shao, Rong ;

Liu, Ying-bin .

MOLECULAR CANCER, 2019, 18 (01)

[10] Long non-coding SBF2-AS1 acting as a competing endogenous RNA to sponge microRNA-142-3p to participate in gemcitabine resistance in pancreatic cancer via upregulating TWF1 [J].

Hua, Yong-Qiang ;

Zhu, Yao-Dong ;

Xie, Guo-Qun ;

Zhang, Ke ;

Sheng, Jie ;

Zhu, Zhen-Feng ;

Ning, Zhou-Yu ;

Chen, Hao ;

Chen, Zhen ;

Meng, Zhi-Qiang ;

Liu, Lu-Ming .

AGING-US, 2019, 11 (20) :8860-8878

← 1 2 3 →